Cleveland Clinic's Breast Cancer Update: Review of Breast Cancer Symposia

 

Cleveland Clinic's Breast Cancer Update: Review of Breast Cancer Symposia
J

8-Year Follow-Up on MINDACT Trial for Adjuvant Chemo in HR+/HER2- BC: Do Genomically Low-Risk Tumors Benefit From Chemo? Is DMFS Improved?

By Cleveland Clinic's Breast Cancer Update: Review of Breast Cancer Symposia FEATURING James Martin
By Cleveland Clinic's Breast Cancer Update: Review of Breast Cancer Symposia FEATURING James Martin
115 views
March 5, 2021
Comments 0
Login to view comments. Click here to Login

Featured Video

03:38
Lilly Medical Affairs

SERDS: Relevance and Role in Current & Future Treatments for HR+…

Feat. K. Jhaveri

Featured Video

06:40
Lilly Medical Affairs

Communicating the Risk of Recurrence for Patients With HR+, HER2- Ea…

Feat. J. O’Shaughnessy
2021
13:53

Cleveland Clinic Expert BC Discussion: Commercial CTC Assays, ILD, R…

Cleveland Clinic's Breast Cancer Update: Review of Breast Cancer Symposia

M. Miller, E. Roesch, J. Abraham

115 views
12:48

Prognostic Models & Biomarker Evaluation in mBC: Does Sacituzumab Go…

Cleveland Clinic's Breast Cancer Update: Review of Breast Cancer Symposia

E. Roesch

98 views
15:48

Correlative Biomarker Analysis of Intrinsic Subtypes and Efficacy Ac…

Cleveland Clinic's Breast Cancer Update: Review of Breast Cancer Symposia

E. Roesch

200 views
28:52

Cleveland Clinic Updates on BC Surgery: How to Refine Axilla Managem…

Cleveland Clinic's Breast Cancer Update: Review of Breast Cancer Symposia

M. Miller

20 views
09:00

Overview of Available Treatment Options in HER2+ MBC: Tucatinib Comb…

Cleveland Clinic's Breast Cancer Update: Review of Breast Cancer Symposia

J. Abraham

235 views
14:19

2021 Update on HER2+ MBC: Neratinib/Cape vs. Lapatinib/Cape in MBC, …

Cleveland Clinic's Breast Cancer Update: Review of Breast Cancer Symposia

J. Abraham

201 views
17:28

Cleveland Clinic Expert Discussion on BC: Chemo Benefit With Ovarian…

Cleveland Clinic's Breast Cancer Update: Review of Breast Cancer Symposia

J. Martin, H. Moore, E. Harris, M. Kruse

24 views
24:29

Cleveland Clinic Updates on IO in mTNBC: Should We Use Atezo With Pa…

Cleveland Clinic's Breast Cancer Update: Review of Breast Cancer Symposia

M. Kruse

172 views
08:07

Cleveland Clinic Updates on IO in Early Stage TNBC: Will pCR Increas…

Cleveland Clinic's Breast Cancer Update: Review of Breast Cancer Symposia

M. Kruse

88 views
21:39

Cleveland Clinic 2021 BC RT Updates: WBRT vs. APBI, 1-Week vs. 3-Wee…

Cleveland Clinic's Breast Cancer Update: Review of Breast Cancer Symposia

E. Harris

26 views
12:24

Breast Cancer Screening and Prevention: Anastrozole vs. Tamoxifen fo…

Cleveland Clinic's Breast Cancer Update: Review of Breast Cancer Symposia

H. Moore

454 views
10:34

BC Survivorship Updates: Diabetes Risk Reduction Diet & Survival, Im…

Cleveland Clinic's Breast Cancer Update: Review of Breast Cancer Symposia

H. Moore

17 views
08:36

2021 RxPONDER Study Update on Early HR+/N+ BC: How Does Chemo Affect…

Cleveland Clinic's Breast Cancer Update: Review of Breast Cancer Symposia

J. Martin

212 views
06:12

8-Year Follow-Up on MINDACT Trial for Adjuvant Chemo in HR+/HER2- BC…

Cleveland Clinic's Breast Cancer Update: Review of Breast Cancer Symposia

J. Martin

115 views
09:22

2021 Update on ET in BC: Palbociclib+ET in HR+/HER2- Normal Disease …

Cleveland Clinic's Breast Cancer Update: Review of Breast Cancer Symposia

J. Martin

132 views